Can Generic Intravenous Levetiracetam Be Used for Acute Repetitive Convulsive Seizure or Status Epilepticus? A Randomized Controlled Trial

INTRODUCTION: Intravenous levetiracetam (IV LEV) is approved for treatment status epilepticus (SE). However, the drug’s high cost must be considered when deciding on a treatment strategy. This study aimed to compare the efficacy of brand-name and generic IV LEV for acute repetitive convulsive seizur...

Descripción completa

Detalles Bibliográficos
Autores principales: Wongjirattikarn, Rachot, Sawanyawisuth, Kittisak, Pranboon, Sineenard, Tiamkao, Siriporn, Tiamkao, Somsak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858918/
https://www.ncbi.nlm.nih.gov/pubmed/31407191
http://dx.doi.org/10.1007/s40120-019-00150-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858918/
https://www.ncbi.nlm.nih.gov/pubmed/31407191
http://dx.doi.org/10.1007/s40120-019-00150-x

Ejemplares similares